# ClinicalTrials.gov record NCT07795164

> PeptideScanner retained ClinicalTrials.gov record NCT07795164 at 2026-09-09T19:17:17.076Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was pemvidutide.

- Evidence object: `story:clinicaltrials-gov-nct07795164-pemvidutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-31
- Source checked: 2026-09-09
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07795164-pemvidutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07795164-pemvidutide-v1.json
- Content SHA-256: `9a26f3027c831b1fe3f6a678d2c2a22becae4109b2f85860ba400d230be01b87`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07795164 ([`ctg-observation-nct07795164-2026-08-31-445923515599`](#source-ctg-observation-nct07795164-2026-08-31-445923515599))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07795164 at 2026-09-09T19:17:17.076Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was pemvidutide. ([`ctg-observation-nct07795164-2026-08-31-445923515599`](#source-ctg-observation-nct07795164-2026-08-31-445923515599))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07795164 at 2026-09-09T19:17:17.076Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was pemvidutide. ([`ctg-observation-nct07795164-2026-08-31-445923515599`](#source-ctg-observation-nct07795164-2026-08-31-445923515599))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07795164-2026-08-31-445923515599`](#source-ctg-observation-nct07795164-2026-08-31-445923515599))

## Sources

<a id="source-ctg-observation-nct07795164-2026-08-31-445923515599"></a>
- **ClinicalTrials.gov record NCT07795164 · retained source version 2026-08-31:445923515599b1c75e5a12a2ec64209d4453be7d93d0614bca15d8035020d448** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07795164) (`ctg-observation-nct07795164-2026-08-31-445923515599`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07795164." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07795164-pemvidutide-v1.json SHA-256: 9a26f3027c831b1fe3f6a678d2c2a22becae4109b2f85860ba400d230be01b87.

